Can Bestivan (Vilire) be taken for a long time and what are the recommendations for the duration of treatment?

Belzutifan is a new HIF-2α inhibitor mainly used to treat solid tumors related to von Hippel-Lindau (VHL) syndrome and some patients with renal cell carcinoma. As a targeted drug, its design goal is to inhibit tumor-related pathways in the long term, thereby delaying disease progression. Theoretically, this drug is a long-term management treatment rather than a drug that can be cured with short-term medication. Therefore, most patients need to decide whether to continue taking it based on disease progression and tolerance.

In clinical practice, it is usually recommended to continue taking besetifan until disease progression occurs or until the patient becomes intolerant of its side effects. This is similar to the treatment schedule for many oral targeted drugs. Research data shows that some patients can still maintain stable disease and have a relatively high quality of life after long-term medication. However, due to obvious individual differences, some patients may experience adverse reactions such as anemia, fatigue or hypoxemia during medication. These conditions require doctors to monitor and make individual adjustments during the course of treatment.

Long-term use of bestivan requires close follow-up management. Patients usually need to undergo routine blood tests, blood oxygen saturation, and liver and kidney function tests regularly to detect potential adverse drug reactions in a timely manner. If serious side effects occur, your doctor may recommend reducing the dose or intermittent use of the medication. In addition, patients should maintain communication with their doctors and record physical changes during medication in order to evaluate efficacy and tolerance and develop a more reasonable continuous medication plan.
In general, bestivan is a targeted drug suitable for long-term use, but not all patients can continue taking the drug without risk. The length of treatment should be comprehensively evaluated based on disease control, side effects, and the patient's overall health status. For patients who can tolerate it, long-term medication may bring better disease control effects; while for patients who are intolerant or have severe adverse reactions, the regimen needs to be adjusted or even other alternative treatments considered. Therefore, the continued use of besetifan must be carried out under the guidance of a professional doctor to ensure maximum safety and efficacy.
Reference: https://www.drugs.com/